Savulescu Warns that “Love-Diminishing” Drugs could be Used for Gay “Conversion Therapy”
By Xavier Symons,
BioEdge
| 10. 12. 2013
In recent years Oxford bioethicist Julian Savulescu has written extensively about the neuro-enhancement of human relationships. In a number of papers, he has studied the ethics of using drugs to strengthen or improve romantic relationships. But how about the use of “individual, voluntary use of love-diminishing biotechnology”? In other words, drugs which would inhibit or reduce love or sexual attraction. If love is essentially chemical, the tap can be turned on or off.
Although this is currently not feasible, Savulescu and co-authors Brian D. Earp and Anders Sandberg warn that drugs could be used to reverse homosexual inclinations. In a controversial paper in the
American Journal of Bioethics: Neuroscience, “
Brave new love: The threat of high-tech ‘conversion’ therapy and the bio-oppression of sexual minorities”, they examine the ethics of using drugs to “normalize” people with atypical sexual desires.
They conclude that the use of conversion drugs on minors should be illegal but “in rare cases” they could be used by consenting adults, even if they are religious fundamentalists. “It seems hard to maintain… that John Stuart Mill’s...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...